Skip to main content Accessibility help
×
Home

Altered neurochemical metabolites in Alzheimer's disease patients with unawareness of deficits

  • Yi-Chun Yeh (a1) (a2) (a3), Cheng-Fang Yen (a1) (a2), Chun-Wei Li (a4), Yu-Ting Kuo (a4) (a5) (a6) (a7), Chia-Hui Chen (a8), Chen-Chang Lee (a9), Gin-Chung Liu (a4) (a5) (a7), Mei-Feng Huang (a1) (a3), Tai-Ling Liu (a1) (a3) and Cheng-Sheng Chen (a1) (a2)...

Abstract

Background:

Unawareness of deficits is common and is associated with poor outcomes in Alzheimer's disease (AD); however, little is known about correlated neurobiochemical changes.

Methods:

Proton magnetic resonance spectroscopy was used to examine neurobiochemical correlates of unawareness of deficits as assessed by the Dementia Deficit Scale in 36 patients with AD. Magnetic resonance spectroscopy spectra were acquired from the anterior cingulate area and right orbitofrontal area. Concentrations of N-acetyl-aspartate (NAA), total creatine, and other neurometabolites were calculated.

Results:

Nineteen (52.8%) participants had relative unawareness of deficits. This condition was negatively correlated with NAA/creatine in the anterior cingulate area (β = −0.36, p = 0.025) and positively correlated with NAA/creatine in the right orbitofrontal area (β = 0.41, p = 0.009) after controlling for dementia severity.

Conclusions:

These findings suggest unawareness of deficits in AD was associated with the altered neurochemical metabolites in the anterior cingulate area and right orbitofrontal area. However, the two areas might have opposite neuronal functions in unawareness of deficits.

Copyright

Corresponding author

Correspondence should be addressed to: Cheng-Sheng Chen and Cheng-Feng Yen, Department of Psychiatry, Kaohsiung Medical University Hospital, #100, Tzyou 1st Rd, Kaohsiung City, Taiwan 807. Phone: +886-7-312-1101, ext. 6816; Fax: +886-7-3134761. Email: sheng@kmu.edu.tw or chfaye@kmu.edu.tw.

References

Hide All
Abe, N., Suzuki, M., Mori, E., Itoh, M. and Fujii, T. (2007). Deceiving others: distinct neural responses of the prefrontal cortex and amygdala in simple fabrication and deception with social interactions. Journal of Cognitive Neuroscience, 19, 287295.
Adalsteinsson, E., Sullivan, E. V., Kleinhans, N., Spielman, D. M. and Pfefferbaum, A. (2000). Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet, 355, 16961697.
Alexopoulos, G. S. (2002). The Cornell Scale for Depression in Dementia Administration & Scoring Guidelines. New York: Cornell Institute of Geriatric Psychiatry, Weill Medical College of Cornell University.
Amanzio, M. et al. (2011). Unawareness of deficits in Alzheimer's disease: role of the cingulate cortex. Brain, 134, 10611076.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association.
Antoine, C., Antoine, P., Guermonprez, P. and Frigard, B. (2004). Awareness of deficits and anosognosia in Alzheimer's disease. Encephale, 30, 570577. (In French)
Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P. M. and Clark, J. B. (1996). Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport, 7, 13971400.
Birken, D. L. and Oldendorf, W. H. (1989). N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neuroscience and Biobehavioral Reviews, 13, 2331.
Botvinick, M. M. (2007). Conflict monitoring and decision making: reconciling two perspectives on anterior cingulate function. Cognitive, Affective & Behavioral Neuroscience, 7, 356366.
Braver, T. S., Barch, D. M., Gray, J. R., Molfese, D. L. and Snyder, A. (2001). Anterior cingulate cortex and response conflict: effects of frequency, inhibition and errors. Cerebral Cortex, 11, 825836.
Bush, G., Luu, P. and Posner, M. I. (2000). Cognitive and emotional influences in anterior cingulate cortex. Trends in Cognitive Sciences, 4, 215222.
Casey, B. J. et al. (1997). The role of the anterior cingulate in automatic and controlled processes: a developmental neuroanatomical study. Developmental Psychobiology, 30, 6169.
Chan, S., Shungu, D. C., Douglas-Akinwande, A., Lange, D. J. and Rowland, L. P. (1999). Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology, 212, 763769.
Cheng, L. L., Newell, K., Mallory, A. E., Hyman, B. T. and Gonzalez, R. G. (2002). Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology. Magnetic Resonance Imaging, 20, 527533.
Clare, L., Wilson, B. A., Carter, G., Roth, I. and Hodges, J. R. (2002). Assessing awareness in early-stage Alzheimer's disease: development and piloting of the Memory Awareness Rating Scale. Neuropsychological Rehabilitation, 12, 341362.
Derouesne, C., Thibault, S., Lagha-Pierucci, S., Baudouin-Madec, V., Ancri, D. and Lacomblez, L. (1999). Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. International Journal of Geriatric Psychiatry, 14, 10191030.
Hanyu, H. et al. (2008). Neuroanatomical correlates of unawareness of memory deficits in early Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 25, 347353.
Harada, T. et al. (2009). Neural correlates of the judgment of lying: a functional magnetic resonance imaging study. Neuroscience Research, 63, 2434.
Howorth, P. and Saper, J. (2003). The dimensions of insight in people with dementia. Aging & Mental Health, 7, 113122.
Ito, A. et al. (2011). The role of the dorsolateral prefrontal cortex in deception when remembering neutral and emotional events. Neuroscience Research, 69, 121128.
Jansen, J. F., Backes, W. H., Nicolay, K. and Kooi, M. E. (2006). 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology, 240, 318332.
Jessen, F. et al. (2001). Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology, 57, 930932.
Johnson, S. C., Baxter, L. C., Wilder, L. S., Pipe, J. G., Heiserman, J. E. and Prigatano, G. P. (2002). Neural correlates of self-reflection. Brain, 125, 18081814.
Kantarci, K. (2007). 1H magnetic resonance spectroscopy in dementia. British Journal of Radiology, 80, S146152.
Kantarci, K. et al. (2007). Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging, 28, 13301339.
Kantarci, K. et al. (2008). Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology, 248, 210220.
Kato, T., Inubushi, T. and Kato, N. (1998). Magnetic resonance spectroscopy in affective disorders. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 133147.
Klunk, W. E., Panchalingam, K., Moossy, J., McClure, R. J. and Pettegrew, J. W. (1992). N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology, 42, 15781585.
Krishnan, K. R. et al. (2003). Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. American Journal of Psychiatry, 160, 20032011.
Lissek, S. et al. (2008). Cooperation and deception recruit different subsets of the theory-of-mind network. PLoS One, 3, e2023.
MacQuarrie, C. R. (2005). Experiences in early stage Alzheimer's disease: understanding the paradox of acceptance and denial. Aging & Mental Health, 9, 430441.
Mangone, C. A. et al. (1991). Impaired insight in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 4, 189193.
Marshall, G. A., Monserratt, L., Harwood, D., Mandelkern, M., Cummings, J. L. and Sultzer, D. L. (2007). Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Archives of Neurology, 64, 10151020.
McDaniel, K. D., Edland, S. D. and Heyman, A. (1995). Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD Clinical Investigators. Consortium to Establish a Registry for Alzheimer's Disease. Alzheimer Disease and Associated Disorders, 9, 101104.
McGlynn, S. M. and Schacter, D. L. (1989). Unawareness of deficits in neuropsychological syndromes. Journal of Clinical and Experimental Neuropsychology, 11, 143205.
Michon, A., Deweer, B., Pillon, B., Agid, Y. and Dubois, B. (1994). Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 57, 805809.
Migliorelli, R. et al. (1995). Anosognosia in Alzheimer's disease: a study of associated factors. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 338344.
Migneco, O. et al. (2001). Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage, 13, 896902.
Miller, B. L., Moats, R. A., Shonk, T., Ernst, T., Woolley, S. and Ross, B. D. (1993). Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology, 187, 433437.
Mimura, M. (2008). Memory impairment and awareness of memory deficits in early-stage Alzheimer's disease. Tohoku Journal of Experimental Medicine, 215, 133140.
Modrego, P. J., Pina, M. A., Fayed, N. and Diaz, M. (2006). Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs, 20, 867877.
Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N. and Namboodiri, A. M. (2007). N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Progress in Neurobiology, 81, 89131.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.
Nakaaki, S. et al. (2008). Impact of depression on insight into memory capacity in patients with Alzheimer disease. Alzheimer Disease and Associated Disorders, 22, 369374.
Northoff, G., Bermpohl, F., Schoeneich, F. and Boeker, H. (2007). How does our brain constitute defense mechanisms? First-person neuroscience and psychoanalysis. Psychotherapy and Psychosomatics, 76, 141153.
Okonkwo, O. C., Spitznagel, M. B., Alosco, M. L. and Tremont, G. (2010). Associations among measures of awareness of cognitive deficits in dementia. Alzheimer's & Dementia, 6, 312318.
Pfefferbaum, A., Adalsteinsson, E., Spielman, D., Sullivan, E. V. and Lim, K. O. (1999). In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magnetic Resonance in Medicine, 41, 276284.
Reed, B. R., Jagust, W. J. and Coulter, L. (1993). Anosognosia in Alzheimer's disease: relationships to depression, cognitive function, and cerebral perfusion. Journal of Clinical and Experimental Neuropsychology, 15, 231244.
Ries, M. L. et al. (2007). Anosognosia in mild cognitive impairment: relationship to activation of cortical midline structures involved in self-appraisal. Journal of the International Neuropsychological Society, 13, 450461.
Ross, B. D. (1991). Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR in Biomedicine, 4, 5963.
Ross, B., Kreis, R. and Ernst, T. (1992). Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. European Journal of Radiology, 14, 128140.
Salmon, E. et al. (2006). Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Human Brain Mapping, 27, 588597.
Schmitz, T. W., Rowley, H. A., Kawahara, T. N. and Johnson, S. C. (2006). Neural correlates of self-evaluative accuracy after traumatic brain injury. Neuropsychologia, 44, 762773.
Shibata, K., Narumoto, J., Kitabayashi, Y., Ushijima, Y. and Fukui, K. (2008). Correlation between anosognosia and regional cerebral blood flow in Alzheimer's disease. Neuroscience Letters, 435, 710.
Snow, A. L., Norris, M. P., Doody, R., Molinari, V. A., Orengo, C. A. and Kunik, M. E. (2004). Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Disease and Associated Disorders, 18, 2231.
Starkstein, S. E., Sabe, L., Chemerinski, E., Jason, L. and Leiguarda, R. (1996). Two domains of anosognosia in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 61, 485490.
Thompson, C. and Spilsbury, K. (2007). WITHDRAWN: Support for carers of people with Alzheimer's type dementia. Cochrane Database Systemic Review, 18, CD000454.
Trouillet, R., Gely-Nargeot, M. C. and Derouesne, C. (2003). Unawareness of deficits in Alzheimer's disease: a multidimentional approach. Psychologie & Neuropsychiatrie du Vieillissement, 1, 99110. (In French)
Urenjak, J., Williams, S. R., Gadian, D. G. and Noble, M. (1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience, 13, 981989.
Valenzuela, M. J. and Sachdev, P. (2001). Magnetic resonance spectroscopy in AD. Neurology, 56, 592598.
Vogel, A., Hasselbalch, S. G., Gade, A., Ziebell, M. and Waldemar, G. (2005). Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease. International Journal of Geriatric Psychiatry, 20, 238246.
Yang, Y. et al. (2007). Localisation of increased prefrontal white matter in pathological liars. British Journal of Psychiatry, 190, 174175.
Zanetti, O. et al. (1999). Insight in dementia: when does it occur? Evidence for a nonlinear relationship between insight and cognitive status. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 54, P100106.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed